Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adrián Rodríguez-Albarrán"'
Autor:
Pablo Moriña-Vázquez, María Teresa Moraleda-Salas, Álvaro López-Masjuan-Ríos, Irene Esteve-Ruiz, Álvaro Arce-León, Carmen Lluch-Requerey, Adrián Rodríguez-Albarrán, José Venegas-Gamero, Antonio Enrique Gómez-Menchero
Publikováno v:
Journal of Interventional Cardiac Electrophysiology.
Autor:
Pablo Moriña-Vázquez, María Teresa Moraleda-Salas, Adrián Rodríguez-Albarrán, Álvaro Arce-León, José Venegas-Gamero, Juan Manuel Fernández-Gómez, Irene Esteve-Ruiz, Rafael Barba-Pichardo
Publikováno v:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.
Cardiac resynchronization therapy (CRT) via permanent His bundle pacing (pHBP) has gained acceptance globally, but robust studies comparing pHBP-CRT with classic CRT are lacking. In this study, we aimed to compare the improvement in left ventricular
Autor:
Adrián Rodríguez Albarrán, María Teresa Moraleda Salas, Álvaro Arce León, Pablo Moriña Vázquez, Juan Manuel Fernández Gómez
Publikováno v:
REC: CardioClinics. 58:S17
Autor:
Marcos García-Aguado, Aitor Uribarri, Carlos Macaya, Gisela Feltez Guzman, Víctor Manuel Becerra-Muñoz, Bernardo Cortese, Carolina Espejo Paeres, Antonio Fernández-Ortiz, Sergio Raposeiras-Roubín, Adrián Rodríguez Albarrán, Francesco Santoro, Natale Daniele Brunetti, Federico Guerra, Ibrahim Akin, Emilio Alfonso-Rodríguez, Juan F Garcia Prieto, Iván J. Núñez-Gil, Inmaculada Fernández Rozas, Jia Huang, Enrica Vitale, Eva Maria Corral Rubio, María C Viana-Llamas, Francisco Marín, Rodolfo Romero-Pareja, Alba Mulet, María Elizabeth Ortega-Armas, Matteo Bianco, Fabrizio Ugo, Jorge Luis Jativa Mendez, Harish Ramakrishna, Begoña Reche-Martinez
Publikováno v:
Heart
BackgroundStandard therapy for COVID-19 is continuously evolving. Autopsy studies showed high prevalence of platelet-fibrin-rich microthrombi in several organs. The aim of the study was therefore to evaluate the safety and efficacy of antiplatelet th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::745b9bd85372c70fe8536e9c0ed70076
https://hdl.handle.net/10668/20155
https://hdl.handle.net/10668/20155
Autor:
Luis Manuel Domínguez-Rodríguez, Rafael Cobas-Paz, David Alonso Rodríguez, Alberto González-Carrero López, Pablo Domínguez-Erquicia, Felipe Fernández Vázquez, Adrián Rodríguez Albarrán, Julia Verísimo Guillén, Álvaro López-Masjuán Ríos, Andrés Íñiguez-Romo, Sergio Raposeiras-Roubín, Naiara Cubelos Fernández, Emad Abu-Assi, José Francisco Díaz Fernández, Isabel Muñoz-Pousa, Julio García Comesaña, Santiago Jesús Camacho Freire, Cristina Barreiro Pardal, Berenice Caneiro-Queija, Sara Álvarez Castañera, María Cespón-Fernández, Carlos Rodríguez Pascual, Alberto Carpintero Vara
Publikováno v:
Journal of the American Medical Directors Association. 21(3)
Objectives Nonagenarian patients are underrepresented in clinical trials that have evaluated oral anticoagulation in patients with atrial fibrillation (AF). The aim of this study was to assess the pronostic impact of oral anticoagulation in patients